Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations

Chagas' disease, caused by Trypanosoma cruzi infection, is one of the main causes of death due to heart failure in Latin American countries. Benznidazole, the chemotherapeutic agent most often used for the treatment of chagasic patients, is highly toxic and has limited efficacy, especially in t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garcia, Simone, Ramos, Carolina O., Senra, Juliana F. V., Vilas-Boas, Fabio, Rodrigues, Maurício M., Campos-de-Carvalho, Antonio C., Ribeiro-dos-Santos, Ricardo, Soares, Milena B. P.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2005
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068607/
https://ncbi.nlm.nih.gov/pubmed/15793134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1521-1528.2005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars